NJ ACTS is excited to announce the awardees of the 2019 Partnership and Innovation Accelerator Pilot Grant Program (PIAP), Usha Ramachandran, MD and Helmut Zarbl, PhD. The New Jersey Alliance for Clinical and Translational Science (NJ ACTS) Community Engagement Core...
Study finds meth undermines success in treatment for opioid-use disorder. Clinician observes link between patients treated for opioid-use disorder and use of methamphetamines. Read more about it in the study published in the Journal of Substance Abuse...
The New Jersey Alliance for Clinical and Translational Science, an academic consortium at the Rutgers Institute for Translational Medicine and Science, celebrated its $29 million grant from the National Institutes of Health with a health care-oriented event last week...
Residents of two Trenton zip codes can expect to live to about 74 years old on average, but in neighboring communities life expectancies can be more than a decade longer. A new study by the Institute for Health, Health Care Policy and Aging Research will explore what...
NJ Spotlight reports outreach vans and emergency responders trained in new treatments are part of the new anti-addiction toolkit that providers are using to expand access to opioid treatment in New Jersey.
